125 results on '"Nortilli R"'
Search Results
2. Renal toxicity and osteonecrosis of the jaw in cancer patients treated with bisphosphonates: a long-term retrospective analysis
3. Prognostic significance of estrogen receptors in 405 primary breast cancers: a comparison of immunohistochemical and biochemical methods
4. Estrogen receptors in 699 primary breast cancers: A comparison of immunohistochemical and biochemical methods
5. Quality of life evaluation in a randomised trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients
6. Comparative study of clinical, pathological and biological characteristics of symptomatic versus asymptomatic breast cancers
7. Basal level and behaviour of cytokines in a randomized outpatient trial comparing chemotherapy and biochemotherapy in metastatic melanoma
8. A propensity score analysis exploring the impact of the addition of adjuvant chemotherapy (aCT) to hormone therapy (aHT) in a multi-center series of resected luminal early stage pure invasive lobular breast carcinoma (ILC)
9. A propensity score analysis exploring the impact of adjuvant chemotherapy (aCT) in 739 patients (pts) affected by early stage pure Invasive Lobular breast Carcinoma (ILC)
10. ESR1, Ph-mTOR, CDK4/6 and PD-L1 expression as prognostic (and potentially druggable) drivers for pure invasive lobular breast carcinoma (ILC): Preliminary results of prognostic outliers according to a clinical-pathological model
11. Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: Prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer
12. Prognostic model for advanced breast carcinoma with luminal subtype and impact of hormonal maintenance: Implications for post-progression and conditional survival
13. Prognostic impact of proliferation for resected early stage breast cancer according to histology: Cut-off analysis of Ki67 in 859 patients with pure invasive lobular and ductal breast carcinoma (ILC/IDC)
14. Prognostic impact of Ki67 for resected early stage pure Invasive Lobular breast Cancer (ILC): cut-off analysis and clinical validation
15. 197P - A propensity score analysis exploring the impact of the addition of adjuvant chemotherapy (aCT) to hormone therapy (aHT) in a multi-center series of resected luminal early stage pure invasive lobular breast carcinoma (ILC)
16. Clinical and pathological predictors of Advanced Breast Carcinoma with Luminal subtype (ABC-Lum) identifying prognostic ‘outliers’: multicenter retrospective analysis in the ‘real-world’ scenario
17. Development of a risk model to identity prognostic ‘outliers’ underwent surgery for early-stage invasive lobular breast carcinoma (ILBC) according to clinical and pathological factors
18. La casistica clinica del Coordinamento Interdisciplinare Melanoma Veronese
19. 204P - ESR1, Ph-mTOR, CDK4/6 and PD-L1 expression as prognostic (and potentially druggable) drivers for pure invasive lobular breast carcinoma (ILC): Preliminary results of prognostic outliers according to a clinical-pathological model
20. L’esperienza del Coordinamento Interdisciplinare Melanoma Veronese (C.I.Me.V.)
21. Carboplatin, doxorubicin and etoposide in the treatment of tumours of unknown primary site
22. Stereotactic radiosurgery in cerebral metastasis from germ cell tumors
23. Ki-67 in 3130 primary breast cancers: associacions with clinical and pathological variables
24. INvolvement of breast CAncer patients during oncological consultations: A multicentre randomised controlled trial-the INCA study protocol
25. A phase II study of gemcitabine (GEM) and vindesine (VDS) in elderly or poor performance patients with unresectable non small cell lung cancer (NSCLC): final results
26. F11 - Prognostic impact of Ki67 for resected early stage pure Invasive Lobular breast Cancer (ILC): cut-off analysis and clinical validation
27. Proliferative activity in 322 breast cancer patients association with prognosis
28. Bone marrow micrometastases in 110 breast cancer patients correlations with clinical-pathological features and prognosis
29. Comparison of two different methods of evaluating proliferative index in breast cancer
30. Ki-67 e risposta alla chemioterapia nel carcinoma mammario avanzato
31. Bone marrow micrometastases in 120 breast cancer patients
32. Trattamento del melanoma con Interferone Alfa e Dacarbazina
33. Il Formestone (4-Idrossiandrostenedione-LentaronR) nel trattamento di pazienti con cr. mammario metastatico
34. Renal toxicity and osteonecrosis of the jaw in cancer patients treated with bisphosphonates: a long-term retrospective analysis
35. Chemioterapia ad alte dosi con trapianto di midollo autologo e fattori di crescita (CSF): razionale, prospettive (problemi di assistenza)
36. Interferon Alfa and Dacarbazina (DTIC) in patients with disseminated malignant melanoma
37. Limite, Trasformazione, Rinascita: rischi 'eccellenti' della crisi
38. Prognosis in breast cancer: significance of estrogen receptors by immunohistochemistry
39. Significato prognostico dell'indice di proliferazione cellulare nel carcinoma mammario
40. 7019 POSTER Long-term outcome of patients with advanced melanoma
41. Micrometastasi midollari in pazienti con carcinoma mammario operabile: studio su 51 casi
42. Correlation of replicative fraction by Ki67 immunohistochemistry (RF) with clinico pathological features and prognosis in breast cancer (B.C.)
43. Micrometastases in bone marrow in breast cancer patients
44. Micrometastases in bone marrow: study in 51 breast cancer patients
45. Significato prognostico e correlazioni clinico patologiche dei recettori per l'estradiolo dosati con metodo biochimico e immunoistochimico
46. Comparison of two different methods for the determination of estrogen receptors (ER) in breast cancer (b.c.)
47. Replicative fraction in breast cancer (b.c.): an immunohistochemical study of 329 cases
48. Attività proliferativa del carcinoma mammario: studio su 329 pazienti
49. Prognostic significance of estrogen receptors (ER), determined by two different methods, in breast cancer (b.c.)
50. The relationship between estrogen receptors (ER) determined by two different methods and prognosis in breast cancer (b.c.)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.